The 12th Annual Head and Neck Conference: "Salvage treatment for head and neck cancer-when, why and how"
After the success of the last eleven years it is with great pleasure that you are invited to participate in the twelfth Royal Marsden Head and Neck Study Day.
Start: 09:00, 06 November 2020
End: 17:00, 06 November 2020
Recurrent head and neck cancer represents an increasing burden of disease and although a variety of therapeutic options exist patients frequently do not have access to them. The evidence base is this field is rapidly changing with the publication of relevant datasets in immunotherapy and robotic surgery. This year we have therefore chosen to focus on salvage treatment for recurrent head and neck cancer.
- Full delegate £180
- Trainees and CNSs £120
11 St Andrews Pl, London NW1 4LE, UK